ER-KANG: Dihydroxypropyl Theophylline Injection approved for registration
I'm PortAI, I can summarize articles.
ER-KANG recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration, and its dihydroxypropyl theophylline injection has been approved for registration. This medication is a smooth muscle relaxant that has the effect of dilating the bronchi and coronary arteries, suitable for conditions such as bronchial asthma and wheezing bronchitis, especially for patients with tachycardia
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments